QUANTITATIVE ACUTE-LEUKEMIA CYTOGENETICS

被引:121
作者
MITELMAN, F [1 ]
HEIM, S [1 ]
机构
[1] ODENSE UNIV,DEPT MED GENET,DK-5230 ODENSE,DENMARK
关键词
D O I
10.1002/gcc.2870050109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using literature data on cytogenetic abnormalities in 3,612 cases of acute myeloid leukemia (AML) and 1,55 1 cases of acute lymphocytic leukemia (ALL), we have attempted to quantify the information value of finding the typical ALL- and AML-associated chromosome aberrations. Sensitivity, specificity, and predictive value of finding or not finding a given aberration were calculated for several diagnostic scenarios: for the differential diagnosis between ALL and AML when the patient is known to have acute leukemia, for the differential diagnosis among AML FAB subtypes in a patient with known AML, and for the differential diagnosis between ALL FAB subtypes in a patient with known ALL The specificities were generally high, close to 1. The highest sensitivities in AML were found for + 8, t(15;17)(q22;q11), t(8;21)(q22;q22), and - 7 (all > 0. 1), and in ALL for t(9;22)(q34;q11), t(4;11)(q21;q23), and + 21 (again all > 0.1). In the AML subtypes, the highest sensitivities were 0.89 for t(15;17)(q22;q11) in M3, followed by 0.40 for t(8;21)(q22;q22) in M2, 0.30 for inv(16)(p13q22)/del(16)(q22)/t(16;16)(p13;q22) in M4, and 0.16 for t(9;11)(p21;q23) in M5. in the ALL subtypes, the highest sensitivities were 0.71 and 0. 11 for t(8;14)(q24;q32) and t(8;22)(q24;q11), respectively, in L3, 0.23 for t(9;22)(q34;q11) in L2, and 0. 18 and 0. 13 for +21 and t(4;11)(q21;q23), respectively, in L1. The highest (1.0) positive predictive values in the AML versus ALL comparison were found for t(1;3)(p36;q21),inv(3)(q2lq26),t(6;9)(p23;q34),t(7;11)(p15;p15),t(8;16)(p11;p13),t(8;21)(q22;q22),t(15;17)(q22;q11),and,as sole anomalies, for +4, +9, and +11. in the reverse comparison, ALL versus AML, positive predictive values of 1.0 were found for t(1;14)(p32-34;q1l), dup(1)(q12-2lq3l-32), t(2;8)(p12;q24), t(8;14)(q24;q32), t/dic(9;12)(p11-12;p11-13), t(10;14)(q24;q11),and t(11;14)(p13;q11).Among the AML subgroups, the highest predictive values were: 1.0 for M3 if t(15;17), 0.91 for M2 if t(8;21), 0.86 for M4 if inv/del(16)/t(16;16),and 0.82 for M5 if t(9;11). Among the ALL subtypes, positive predictive values of > 0.8 were reached only for the L3-associated aberrations t(2;8) (1.0), t(8; 14) (0.95), t(8;22) (0.87), and dup(1) (0.80). The highest negative predictive values were in AML 0.98 that the disease is not M3 if t(15;17) is not found, and in ALL 0.96 that the patient does not have L3 if a t(8;14) is not detected.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 21 条
[1]   CRITERIA FOR THE DIAGNOSIS OF ACUTE-LEUKEMIA OF MEGAKARYOCYTE LINEAGE (M7) - A REPORT OF THE FRENCH-AMERICAN-BRITISH COOPERATIVE GROUP [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) :460-462
[2]   PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&
[3]  
BENNETT JM, 1985, ANN INTERN MED, V103, P626
[4]   PHILADELPHIA-POSITIVE ACUTE-LEUKEMIA - CYTOGENETIC AND MOLECULAR ASPECTS [J].
BERGER, R ;
CHEN, SJ ;
CHEN, Z .
CANCER GENETICS AND CYTOGENETICS, 1990, 44 (02) :143-152
[5]   MOLECULAR ANALYSIS OF ACUTE PROMYELOCYTIC LEUKEMIA BREAKPOINT CLUSTER REGION ON CHROMOSOME-17 [J].
BORROW, J ;
GODDARD, AD ;
SHEER, D ;
SOLOMON, E .
SCIENCE, 1990, 249 (4976) :1577-1580
[6]   THE T(15-17) TRANSLOCATION OF ACUTE PROMYELOCYTIC LEUKEMIA FUSES THE RETINOIC ACID RECEPTOR-ALPHA GENE TO A NOVEL TRANSCRIBED LOCUS [J].
DETHE, H ;
CHOMIENNE, C ;
LANOTTE, M ;
DEGOS, L ;
DEJEAN, A .
NATURE, 1990, 347 (6293) :558-561
[7]  
Groffen John, 1989, Critical Reviews in Oncogenesis, V1, P53
[8]  
Heim S, 1990, Baillieres Clin Haematol, V3, P921, DOI 10.1016/S0950-3536(05)80141-6
[9]   SECONDARY CHROMOSOME-ABERRATIONS IN THE ACUTE LEUKEMIAS [J].
HEIM, S ;
MITELMAN, F .
CANCER GENETICS AND CYTOGENETICS, 1986, 22 (04) :331-338
[10]  
HEIM S, 1987, CANCER CYTOGENETICS